SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-008831
Filing Date
2018-08-13
Accepted
2018-08-10 18:31:29
Documents
74
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT azrx10q_jun302018.htm 10-Q 1005911
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 16601
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 16671
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32 9736
  Complete submission text file 0001654954-18-008831.txt   3536638

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT azrx-20180630.xml EX-101.INS 539607
6 XBRL TAXONOMY EXTENSION SCHEMA azrx-20180630.xsd EX-101.SCH 47938
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azrx-20180630_cal.xml EX-101.CAL 48841
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azrx-20180630_def.xml EX-101.DEF 108723
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE azrx-20180630_lab.xml EX-101.LAB 250439
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azrx-20180630_pre.xml EX-101.PRE 208069
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37853 | Film No.: 181009991
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences